Tateda K, Ishii Y, Matsumoto T, Furuya N, Nagashima M, Matsunaga T, Ohno A, Miyazaki S, Yamaguchi K
Department of Microbiology, Toho University School of Medicine, Tokyo, Japan.
Antimicrob Agents Chemother. 1996 Oct;40(10):2271-5. doi: 10.1128/AAC.40.10.2271.
Several previous investigators have reported that long-term administration of certain macrolides is efficacious in patients with persistent pulmonary Pseudomonas aeruginosa infections, even though the clinically achievable concentrations of these medications are far below their MICs. In the present study, we examined how sub-MICs of macrolide antibiotics affect the viability of and protein synthesis in several strains of P. aeruginosa. We report that 48 h, but not 12 or 24 h, of growth on agar containing a clinically achievable concentration of azithromycin (0.5 microgram/ml, 1/128 the MIC) significantly reduces the viability of strain PAO-1. Similar effects were seen with erythromycin and clarithromycin at 2 micrograms/ml (1/128 and 1/64 the respective MICs), whereas josamycin, oleandomycin, ceftazidime, tobramycin, minocycline, and ofloxacin had no effect on viability, even following 48 h of incubation with concentrations representing relatively high fractions of their MICs. The bactericidal activity of azithromycin seen following 48 h of incubation was not limited to strain PAO-1 but was also seen against 13 of 14 clinical isolates, including both mucoid and nonmucoid strains. Although viability was not decreased prior to 48 h, we found that 4 micrograms of azithromycin per ml inhibits protein synthesis after as little as 12 h and that protein synthesis continues to decrease in a time-dependent manner. We likewise found that P. aeruginosa accumulates azithromycin intracellulary over the period from 12 to 36 h. These results suggested that sub-MICs of certain macrolides are bactericidal to P. aeruginosa when the bacteria are exposed to these antibiotics for longer periods. Exposure-dependent intracellular accumulation of the antibiotic and inhibition of protein synthesis may partially account for the antipseudomonal activity of macrolides over relatively prolonged incubation periods.
几位先前的研究者报告称,长期使用某些大环内酯类药物对持续性肺部铜绿假单胞菌感染患者有效,尽管这些药物在临床上所能达到的浓度远低于其最低抑菌浓度(MIC)。在本研究中,我们研究了大环内酯类抗生素的亚MIC浓度如何影响几种铜绿假单胞菌菌株的活力和蛋白质合成。我们报告称,在含有临床可达到浓度的阿奇霉素(0.5微克/毫升,为MIC的1/128)的琼脂上生长48小时,但不是12或24小时,会显著降低PAO-1菌株的活力。红霉素和克拉霉素在2微克/毫升(分别为各自MIC的1/128和1/64)时也观察到类似效果,而交沙霉素、竹桃霉素、头孢他啶、妥布霉素、米诺环素和氧氟沙星即使在与代表其MIC相对较高比例的浓度孵育48小时后,对活力也没有影响。孵育48小时后观察到的阿奇霉素的杀菌活性不仅限于PAO-1菌株,对14株临床分离株中的13株也有作用,包括黏液型和非黏液型菌株。尽管在48小时之前活力没有下降,但我们发现每毫升4微克阿奇霉素在仅12小时后就抑制蛋白质合成,并且蛋白质合成继续以时间依赖性方式下降。我们同样发现铜绿假单胞菌在12至36小时内会在细胞内积累阿奇霉素。这些结果表明,当细菌长时间暴露于某些大环内酯类药物的亚MIC浓度时,这些药物对铜绿假单胞菌具有杀菌作用。抗生素的暴露依赖性细胞内积累和蛋白质合成的抑制可能部分解释了大环内酯类药物在相对较长孵育期内的抗假单胞菌活性。